Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India EP News Bureau Feb 6, 2023 It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
Union Budget 2023: Industry lauds focus on R&D EP News Bureau Feb 1, 2023 Pharma leaders and experts share their views on Union Budget 2023 and give insights on the impact of the measures